Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group-Reference-Cited by-同舟云学术

Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group

Published:2023-02 Issue:1 Volume:21 Page:43-54
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Ilario Eder N.^ORCID,Bastos Diogo A.,Guglielmetti Giuliano B.^ORCID,Murta Claudio B.,Cardili Leonardo^ORCID,Cordeiro Mauricio D.,Junior Jose P.^ORCID,Coelho Rafael F.,Nahas William C.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference40 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Time trends and local variation in primary treatment of localized prostate cancer;Cooperberg;J Clin Oncol,2010

3. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods;Yossepowitch;J Urol,2007

4. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2021

5. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era;Stephenson;J Clin Oncol,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and Staging Intensification Strategies Associated with Radical Prostatectomy for High-Risk Prostate Cancer: Efficacy Evaluation and Exploration of Novel Approaches;Cancers;2024-07-05

2. Cardiovascular and Thromboembolic Events in Patients With Localized Prostate Cancer Receiving Intensified Neoadjuvant Androgen Deprivation: A Systematic Review and Meta-Analysis;Clinical Genitourinary Cancer;2024-06

3. The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review;Minerva Urology and Nephrology;2024-05

4. Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer;Frontiers in Pharmacology;2023-10-19

5. Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review;Journal of Personalized Medicine;2023-04-07